Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
FGFR4: A promising therapeutic target for breast cancer and other solid tumors.
Pharmacol Ther. 2020 Oct;214:107590. doi: 10.1016/j.pharmthera.2020.107590. Epub 2020 May 31.
Pharmacol Ther. 2020.
PMID: 32492514
Free PMC article.
Review.
Loss of E-cadherin Induces IGF1R Activation and Reveals a Targetable Pathway in Invasive Lobular Breast Carcinoma.
Elangovan A, Hooda J, Savariau L, Puthanmadhomnarayanan S, Yates ME, Chen J, Brown DD, McAuliffe PF, Oesterreich S, Atkinson JM, Lee AV.
Elangovan A, et al.
Mol Cancer Res. 2022 Sep 2;20(9):1405-1419. doi: 10.1158/1541-7786.MCR-22-0090.
Mol Cancer Res. 2022.
PMID: 35665642
Free PMC article.
Item in Clipboard
FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype.
Levine KM, Priedigkeit N, Basudan A, Tasdemir N, Sikora MJ, Sokol ES, Hartmaier RJ, Ding K, Ahmad NZ, Watters RJ, Weiss KR, Blohmer JU, Denkert C, Machleidt A, Karsten MM, Boisen MM, Elishaev E, Lucas PC, Lee AV, Oesterreich S.
Levine KM, et al.
NPJ Breast Cancer. 2019 Jun 27;5:19. doi: 10.1038/s41523-019-0114-x. eCollection 2019.
NPJ Breast Cancer. 2019.
PMID: 31263748
Free PMC article.
Item in Clipboard
Cite
Cite